Who
Norbert G. Riedel
Director
Company insider
Files Form 4 as: Director, Jazz Pharmaceuticals; Director, Eton Pharmaceuticals; Director, Cerevel Therapeutics Holdings; Executive Chairman of the Bod, Aptinyx; Director, Ariad Pharmaceuticals; Corporate Vice President, Baxter International; Director, Oscient Pharmaceuticals.
In numbers
- Trades disclosed
- 207
- Buys
- 4
- Sells
- 21
- Bought
- $396K
- Sold
- $29.2M
- Companies
- 7
- Companies where not an officer
- 5
- First trade
- 14 Mar 2006
- Last trade
- 31 Aug 2026
- Last filed
- 2 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 31 Aug 2026filed 2 Sep 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $3,42514 at $244.64 | filing |
| 31 Aug 2026filed 2 Sep 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $408K1,692 at $241.39 | filing |
| 31 Aug 2026filed 2 Sep 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $3,42514 at $244.64 | filing |
| 31 Aug 2026filed 2 Sep 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $408K1,692 at $241.39 | filing |
| 5 Aug 2026filed 7 Aug 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —1,605 at $0.00 | filing |
| 5 Aug 2026filed 7 Aug 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —1,605 at $0.00 | filing |
| 31 Jul 2026filed 4 Aug 2026 | ETON Eton Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 31 Jul 2026filed 4 Aug 2026 | ETON Eton Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 21 Apr 2026filed 22 Apr 2026 | ETON Eton PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | $91K12,500 at $7.31 | filing |
| 21 Apr 2026filed 22 Apr 2026 | ETON Eton PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | $169K19,655 at $8.61 | filing |
| 21 Apr 2026filed 22 Apr 2026 | ETON Eton Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —12,500 at $0.00 | filing |
| 21 Apr 2026filed 22 Apr 2026 | ETON Eton Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —12,500 at $0.00 | filing |
| 21 Apr 2026filed 22 Apr 2026 | ETON Eton Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —19,655 at $0.00 | filing |
| 21 Apr 2026filed 22 Apr 2026 | ETON Eton Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —19,655 at $0.00 | filing |
| 21 Apr 2026filed 22 Apr 2026 | ETON Eton PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | $91K12,500 at $7.31 | filing |
| 21 Apr 2026filed 22 Apr 2026 | ETON Eton PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | $169K19,655 at $8.61 | filing |
| 27 Feb 2026filed 2 Mar 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | $472K3,415 at $138.08 | filing |
| 27 Feb 2026filed 2 Mar 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $656K3,415 at $192.00 | filing |
| 27 Feb 2026filed 2 Mar 2026 | JAZZ Jazz Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —3,415 at $0.00 | filing |
| 27 Feb 2026filed 2 Mar 2026 | JAZZ Jazz Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —3,415 at $0.00 | filing |
News
Jazz Pharmaceuticals gets Cramer's vote of confidenceJAZZ · aol.com · 14 Oct 2026Critical Analysis: vTv Therapeutics (NASDAQ:VTVT) and Jazz Pharmaceuticals (NASDAQ:JAZZ)JAZZ · tickerreport.com · 12 Oct 2026Cramer's lightning round: 'I'm going to say yes to Jazz Pharmaceuticals'JAZZ · cnbc.com · 10 Oct 2026
0 headlines in the last 90 days name Norbert G. Riedel; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.